Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Pharma companies continue to increase AI investment, but expected gains in development timelines and success rates remain limited. In an August 10, 2026 analysis for Pharmaceutical Technology, Brian Drapeau argues that workforce qualification may be the missing link. The issue
Explore how Pharma 4.0, smart manufacturing, IoT, artificial intelligence, and digital quality management reshape pharmaceutical operations. This guide explains the GMP controls, data integrity safeguards, validation evidence, and inspection-ready practices companies need for secure digital transformation.